Results 11 to 20 of about 12,242 (218)

Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine [PDF]

open access: yesThe Journal of Infectious Diseases, 2019
Abstract Background Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes severe flu-like symptoms. The acute symptoms disappear after 1 week, but chronic arthralgia can persist for years.
Lisa Henss   +7 more
core   +7 more sources

FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design [PDF]

open access: yesNature Communications, 2023
Arthritogenic alphaviruses are positive-strand RNA viruses that cause debilitating musculoskeletal diseases affecting millions worldwide. A recent discovery identified the four-and-a-half-LIM domain protein 1 splice variant A (FHL1A) as a crucial host ...
Wern Hann Ng   +16 more
doaj   +2 more sources

Calpain-2 protein influences chikungunya virus replication and regulates vimentin rearrangement caused by chikungunya virus infection

open access: yesFrontiers in Microbiology, 2023
Chikungunya fever (CHIF), a vector-borne disease transmitted mainly by Aedes albopictus and Aedes aegypti, is caused by Chikungunya virus (CHIKV) infection. To date, it is estimated that 39% of the world’s population is at risk of infection for living in
Jia Li   +8 more
doaj   +1 more source

The research progress of Chikungunya fever

open access: yesFrontiers in Public Health, 2023
Chikungunya fever, an acute infectious disease caused by Chikungunya virus (CHIKV), is transmitted by Aedes aegypti mosquitoes, with fever, rash, and joint pain as the main features.
Li Cai   +8 more
doaj   +1 more source

LABORATORY INVESTIGATION OF CHIKUNGUNYA OUTBREAK IN PERAK FROM 2019 TO 2020

open access: yesInternational Journal of Infectious Diseases, 2023
Intro: Chikungunya virus (CHIKV) is a vector-borne virus which is transmitted primarily by Aedes aegypti and Aedes albopictus. A period between 2016 to 2020, chikungunya outbreaks were reported in several Asian countries. In Perak, Malaysia, there was an
Y.Z. Lim
doaj   +1 more source

ViennaRNA/CHIKV: CHIKVnext v5.1 [PDF]

open access: yes, 2023
CHIKVnext is an interactive resource to study the evolution and global spread of Chikungunya virus (CHIKV), built on the Nextstrain platform.
Michael T. Wolfinger   +2 more
core   +1 more source

Mathematical analysis and control of chikungunya (CHIKV) virus by SEIR model

open access: yesInternational journal of health sciences, 2022
Chikungunya is a re-emerging arboviral disease in Asia and Africa infected by Aedes mosquitoes which had posed a global threat in several countries. Vector borne diseases are the primary cause of death in most of the world countries, hence it becomes pertinent to control these vector borne diseases.
Seema Singla, Madhuchanda Rakshit
openaire   +1 more source

A Mouse Model for Studying Post-Acute Arthritis of Chikungunya

open access: yesMicroorganisms, 2021
Chikungunya virus (CHIKV) was introduced to the Americas in 2013, causing two million infections across over thirty countries. CHIKV causes a chronic debilitating arthritis in one fourth of infected individuals and currently evidence-based targeted ...
Aileen Y. Chang   +9 more
doaj   +1 more source

Treatment of Chikungunya Virus (CHIKV) Using Targeted Immunotherapy

open access: yes, 2022
Chikungunya virus (CHIKV) is the most common mosquito-borne Alphavirus infecting humans worldwide. Up to date, there are no antiviral treatments or vaccines approved to treat or prevent CHIKV for which treatments remain symptomatic based on clinical manifestations.
Fleury Augustin Nsole Biteghe   +5 more
openaire   +2 more sources

Chikungunya Virus [PDF]

open access: yes, 2022
The chikungunya virus (CHIKV) is an RNA virus that is transmitted to humans by Aedes mosquitos commonly found in tropical and subtropical countries. In humans, CHIKV causes an infection with symptoms strikingly like those of the dengue virus and Zika ...

core   +1 more source

Home - About - Disclaimer - Privacy